Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 12, 2012

View Archived Issues

Pilot trial evaluates rebamipide in aspirin-induced small bowel damage

Japanese study supports in vivo antitumor activity of Golgi-disrupting agent

Xenon Pharmaceuticals enters alliance for pain therapeutics

Sangamo BioSciences begins two phase II trials in HIV

JNK inhibitor prevents hearing loss due to transient cochlear ischemia in preclinical study

Researchers describe role of Th17 cells in vaccine-induced immunity

Chinese company patents new receptor tyrosine kinase inhibitors

Janssen Pharmaceutica patents novel antifungal agents

Baxter submits supplemental BLA to FDA for Gammagard Liquid

Isis Pharmaceuticals reports phase I data on ISIS-TTRRx

University of Arkansas discloses novel vaccine vectors for Campylobacter infections

Tetragenetics flu vaccine protects against H5N1 in preclinical study

HGS provides pipeline update and goals for 2012

Novel serine/threonine-protein kinase PAK inhibitors patented by Afraxis

Guilin Sanjin Pharmaceutical claims novel saponins

Celtaxsys obtains anti-inflammatory drug from Estrellita Pharmaceuticals

Akinion begins treatment in phase I/II AKN-028 study

Scientists at Gene Signal disclose new peptides for wound healing

Lexicon Pharmaceuticals reports topline data from LX-4211/sitagliptin combination trial

Forma Therapeutics enters into exclusive alliance

EC adopts opinion on pioglitazone-containing drugs

Akebia Therapeutics spin-out company created

Biocon reports phase III data on immunotherapy for chronic plaque psoriasis

Cynapsus Therapeutics reports encouraging first-in-human data on APL-130277

Kadmon acquires anticancer candidate from Concordia Pharmaceuticals

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...